Reduction in HPV16/18 prevalence among young women with high‐grade cervical lesions following the Japanese HPV vaccination program

Guidelines for office gynecology in Japan: Japan Society of Obstetrics and Gynecology (JSOG) and Japan Association of Obstetricians and Gynecologists (JAOG) 2017 edition

(2019) Ryuji Kawaguchi et al.   JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH

Trends in Human Papillomavirus Vaccine Types 16 and 18 in Cervical Precancers, 2008–2014

(2019) Nancy M. McClung et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study

(2019) Tim Palmer et al.   BMJ-British Medical Journal

Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis

(2019) Mélanie Drolet et al.   LANCET

Final analysis of a study assessing genital human papillomavirus genoprevalence in young Australian women, following eight years of a national vaccination program

(2018) Suzanne M. Garland et al.   VACCINE

Effectiveness of HPV vaccination against high grade cervical lesions in Japan

(2018) Ryo Konno et al.   VACCINE

Dynamic changes in Japan’s prevalence of abnormal findings in cervical cervical cytology depending on birth year

(2018) Yutaka Ueda et al.   Scientific Reports

OUP accepted manuscript

(2018)   JOURNAL OF INFECTIOUS DISEASES

Early impact of the Japanese immunization program implemented before the HPV vaccination crisis

(2017) Koji Matsumoto et al.   INTERNATIONAL JOURNAL OF CANCER

Preventive effect of human papillomavirus vaccination on the development of uterine cervical lesions in young Japanese women

(2017) Hidenori Tanaka et al.   JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH

Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional study

(2017) Kimberley Kavanagh et al.   LANCET INFECTIOUS DISEASES

Realistic fear of cervical cancer risk in Japan depending on birth year

(2017) Asami Yagi et al.   Human Vaccines & Immunotherapeutics

Outcomes for girls without HPV vaccination in Japan

(2016) Yusuke Tanaka et al.   LANCET ONCOLOGY

Beneficial Effects of Human Papillomavirus Vaccine for Prevention of Cervical Abnormalities in Miyagi, Japan

(2016) Nobuyoshi Ozawa et al.   TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE

HPV vaccination crisis in Japan

(2015) Sharon J B Hanley et al.   LANCET

A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women

(2015) Elmar A. Joura et al.   NEW ENGLAND JOURNAL OF MEDICINE

Monitoring the Impact of a National HPV Vaccination Program in Japan (MINT Study): Rationale, Design and Methods

(2014) K. Matsumoto et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Effectiveness of quadrivalent human papillomavirus vaccine for the prevention of cervical abnormalities: case-control study nested within a population based screening programme in Australia

(2014) E. Crowe et al.   BMJ-British Medical Journal

Reduction in Human Papillomavirus (HPV) Prevalence Among Young Women Following HPV Vaccine Introduction in the United States, National Health and Nutrition Examination Surveys, 2003–2010

(2013) Lauri E. Markowitz et al.   JOURNAL OF INFECTIOUS DISEASES

Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis

(2012) Talía Malagón et al.   LANCET INFECTIOUS DISEASES

Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study

(2011) Julia ML Brotherton et al.   LANCET

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

(2009) J Paavonen et al.   LANCET